Search our science
Search our scientific publications and resources
on rare bleeding disorders
Scientific resources from Novo Nordisk
Novo Nordisk supports sharing of the scientific research on our molecules. The search results below include peer-reviewed articles that are authored by Novo Nordisk employees or are funded by Novo Nordisk, as well as congress abstracts, posters and presentations, and also related educational resources.
We found 359 resources matching your search criteria
Brian Lauritzen, Mads Bjelke, Marie Rossen, Mikala Skydsgaard, Marianne Kjalke, Olle Björkdahl, Stine L Kjellev; A Novel Next-Generation FVIII Mimetic, Mim8, Has a Favourable Safety Profile. Results from a 26-Week Safety Study in Cynomolgus Monkeys. Blood 2020; 136 (Supplement 1): 26–27. doi: https://doi.org/10.1182/blood-2020-137006
Chowdary, P. (2020), N8?GP: A new extended half?life recombinant factor VIII product for hemophilia A. J Thromb Haemost, 18: 3-4.
Chan AK, Alamelu J, Barnes C, et al. Nonacog beta pegol (N9-GP) in hemophilia B: First report on safety and efficacy in previously untreated and minimally treated patients. Res Pract Thromb Haemost. 2020;00:1–13.